| Year |
Citation |
Score |
| 2024 |
Joseph S, Jadav M, Solanki R, Patel S, Pooja D, Kulhari H. Synthesis, characterization, and application of honey stabilized inulin nanoparticles as colon targeting drug delivery carrier. International Journal of Biological Macromolecules. 130274. PMID 38373569 DOI: 10.1016/j.ijbiomac.2024.130274 |
0.456 |
|
| 2023 |
Jadav M, Solanki R, Patel S, Pooja D, Kulhari H. Development of thiolated xanthan gum-stearylamine conjugate based mucoadhesive system for the delivery of biochanin-A to melanoma cells. International Journal of Biological Macromolecules. 257: 128693. PMID 38092110 DOI: 10.1016/j.ijbiomac.2023.128693 |
0.511 |
|
| 2023 |
Ghosh M, Hazarika P, Dhanya SJ, Pooja D, Kulhari H. Exploration of sialic acid receptors as a potential target for cancer treatment: A comprehensive review. International Journal of Biological Macromolecules. 257: 128415. PMID 38029891 DOI: 10.1016/j.ijbiomac.2023.128415 |
0.371 |
|
| 2023 |
Solanki R, Jangid AK, Jadav M, Kulhari H, Patel S. Folate Functionalized and Evodiamine-Loaded Pluronic Nanomicelles for Augmented Cervical Cancer Cell Killing. Macromolecular Bioscience. e2300077. PMID 37163974 DOI: 10.1002/mabi.202300077 |
0.426 |
|
| 2023 |
Rai DB, Medicherla K, Pooja D, Kulhari H. Dendrimer-Mediated Delivery of Anticancer Drugs for Colon Cancer Treatment. Pharmaceutics. 15. PMID 36986662 DOI: 10.3390/pharmaceutics15030801 |
0.464 |
|
| 2023 |
Jadav M, Pooja D, Adams DJ, Kulhari H. Advances in Xanthan Gum-Based Systems for the Delivery of Therapeutic Agents. Pharmaceutics. 15. PMID 36839724 DOI: 10.3390/pharmaceutics15020402 |
0.481 |
|
| 2023 |
Jat S, Bhatt M, Roychowdhury S, Dixit VA, Pawar SD, Kulhari H, Alexander A, Kumar P. Preparation and characterization of amoxapine- and naringin-loaded solid lipid nanoparticles: drug-release and molecular-docking studies. Nanomedicine (London, England). PMID 36786368 DOI: 10.2217/nnm-2022-0167 |
0.383 |
|
| 2022 |
Tunki L, Ganthala PD, Pooja D, Andugulapati SB, Kulhari H, Sistla R, Bhargava SK. Ameliorating the antitumor activity of gemcitabine against breast tumor using αβ integrin-targeting lipid nanoparticles. Drug Development and Industrial Pharmacy. 1-13. PMID 36047536 DOI: 10.1080/03639045.2022.2120492 |
0.424 |
|
| 2022 |
Chauhan S, Patel K, Jain P, Jangid AK, Patel S, Medicherla K, Limbad K, Mehta C, Kulhari H. Matrix Metalloproteinase Enzyme Responsive Delivery of 5-Fluorouracil Using Collagen-I Peptide Functionalized Dendrimer-Gold Nanocarrier. Drug Development and Industrial Pharmacy. 1-14. PMID 35983681 DOI: 10.1080/03639045.2022.2113404 |
0.456 |
|
| 2022 |
Jangid AK, Solanki R, Patel S, Medicherla K, Pooja D, Kulhari H. Improving Anticancer Activity of Chrysin using Tumor Microenvironment pH-Responsive and Self-Assembled Nanoparticles. Acs Omega. 7: 15919-15928. PMID 35571829 DOI: 10.1021/acsomega.2c01041 |
0.481 |
|
| 2022 |
Jangid AK, Solanki R, Patel S, Pooja D, Kulhari H. Genistein encapsulated inulin-stearic acid bioconjugate nanoparticles: Formulation development, characterization and anticancer activity. International Journal of Biological Macromolecules. 206: 213-221. PMID 35181329 DOI: 10.1016/j.ijbiomac.2022.02.031 |
0.484 |
|
| 2021 |
Kourani K, Jain P, Kumar A, Jangid AK, Swaminathan G, Durgempudi VR, Jose J, Reddy R, Pooja D, Kulhari H, Kumar LD. Inulin coated MnO nanocuboids coupled with RNA interference reverse intestinal tumorigenesis in Apc knockout murine colon cancer models. Nanomedicine : Nanotechnology, Biology, and Medicine. 40: 102504. PMID 34890821 DOI: 10.1016/j.nano.2021.102504 |
0.396 |
|
| 2021 |
Jain P, Patel K, Kumar Jangid A, Guleria A, Patel S, Pooja D, Kulhari H. Biotinylated MnO Nanocuboids for Targeted Delivery of Gemcitabine hydrochloride to Breast Cancer and MRI applications. International Journal of Pharmaceutics. 120895. PMID 34280487 DOI: 10.1016/j.ijpharm.2021.120895 |
0.467 |
|
| 2020 |
Tunki L, Jangid AK, Pooja D, Bhargava SK, Sistla R, Kulhari H. Serotonin-Functionalized Vit-E Nanomicelles for Targeting of Irinotecan to Prostate Cancer Cells. Acs Applied Bio Materials. 3: 5093-5102. PMID 35021685 DOI: 10.1021/acsabm.0c00579 |
0.457 |
|
| 2020 |
Jain P, Patel K, Jangid AK, Guleria A, Patel S, Pooja D, Kulhari H. Modulating the Delivery of 5-Fluorouracil to Human Colon Cancer Cells Using Multifunctional Arginine-Coated Manganese Oxide Nanocuboids with MRI Properties. Acs Applied Bio Materials. 3: 6852-6864. PMID 35019347 DOI: 10.1021/acsabm.0c00780 |
0.433 |
|
| 2020 |
Karamchedu S, Tunki L, Kulhari H, Pooja D. Morin Hydrate Loaded Solid lipid nanoparticles: Characterization, Stability, Anticancer activity, and Bioavailability. Chemistry and Physics of Lipids. 104988. PMID 33035545 DOI: 10.1016/j.chemphyslip.2020.104988 |
0.46 |
|
| 2020 |
Jangid AK, Agraval H, Rai DB, Jain P, Yadav UC, Pooja D, Kulhari H. Baicalin Encapsulating Lipid-Surfactant Conjugate Based Nanomicelles: Preparation, Characterization and Anticancer Activity. Chemistry and Physics of Lipids. 104978. PMID 32991905 DOI: 10.1016/j.chemphyslip.2020.104978 |
0.368 |
|
| 2020 |
Pooja D, Srinivasa Reddy T, Kulhari H, Kadari A, Adams DJ, Bansal V, Sistla R. N-acetyl-D-glucosamine-conjugated PAMAM Dendrimers as Dual Receptor-Targeting Nanocarriers for Anticancer Drug Delivery. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 32717387 DOI: 10.1016/J.Ejpb.2020.07.020 |
0.489 |
|
| 2020 |
Jangid AK, Agraval H, Gupta N, Jain P, Yadav UCS, Pooja D, Kulhari H. Amorphous Nano Morin Outperforms Native Molecule in Anticancer Activity and Oral Bioavailability. Drug Development and Industrial Pharmacy. 1-29. PMID 32469607 DOI: 10.1080/03639045.2020.1776318 |
0.427 |
|
| 2020 |
Gupta N, Bhagat S, Singh M, Jangid AK, Bansal V, Singh S, Pooja D, Kulhari H. Site-specific delivery of a natural chemotherapeutic agent to human lung cancer cells using biotinylated 2D rGO nanocarriers. Materials Science & Engineering. C, Materials For Biological Applications. 112: 110884. PMID 32409041 DOI: 10.1016/j.msec.2020.110884 |
0.381 |
|
| 2020 |
Jain P, Bhagat S, Tunki L, Jangid AK, Singh S, Pooja D, Kulhari H. Serotonin-Stearic Acid Bioconjugate Coated Completely Biodegradable Mn3O4 Nanocuboids for Hepatocellular Carcinoma Targeting. Acs Applied Materials & Interfaces. PMID 32045206 DOI: 10.1021/acsami.0c00331 |
0.408 |
|
| 2019 |
Pooja D, Gunukula A, Gupta N, Adams DJ, Kulhari H. Bombesin Receptors as Potential Targets for Anticancer Drug Delivery and Imaging. The International Journal of Biochemistry & Cell Biology. 105567. PMID 31295552 DOI: 10.1016/J.Biocel.2019.105567 |
0.556 |
|
| 2019 |
Tunki L, Kulhari H, Vadithe LN, Kuncha M, Bhargava S, Pooja D, Sistla R. Modulating the site-specific oral delivery of sorafenib using sugar-grafted nanoparticles for hepatocellular carcinoma treatment. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 104978. PMID 31254645 DOI: 10.1016/j.ejps.2019.104978 |
0.4 |
|
| 2019 |
Kulhari H, Jangid AK, Adams DJ. Monoclonal Antibody-Conjugated Dendritic Nanostructures for siRNA Delivery. Methods in Molecular Biology (Clifton, N.J.). 1974: 195-201. PMID 31099004 DOI: 10.1007/978-1-4939-9220-1_14 |
0.455 |
|
| 2019 |
Radhakrishnan R, Pooja D, Kulhari H, Gudem S, Ravuri HG, Bhargava S, Ramakrishna S. Bombesin Conjugated Solid Lipid Nanoparticles for Improved Delivery of Epigallocatechin Gallate for Breast Cancer Treatment. Chemistry and Physics of Lipids. PMID 30965023 DOI: 10.1016/j.chemphyslip.2019.04.005 |
0.487 |
|
| 2019 |
Weerathunge P, Pooja D, Singh M, Kulhari H, Mayes EL, Bansal V, Ramanathan R. Transferrin-conjugated quasi-cubic SPIONs for cellular receptor profiling and detection of brain cancer Sensors and Actuators B: Chemical. 297: 126737. DOI: 10.1016/J.Snb.2019.126737 |
0.403 |
|
| 2018 |
Jangid AK, Agraval H, Gupta N, Yadav UCS, Sistla R, Pooja D, Kulhari H. Designing of fatty acid-surfactant conjugate based nanomicelles of morin hydrate for simultaneously enhancing anticancer activity and oral bioavailability. Colloids and Surfaces. B, Biointerfaces. 175: 202-211. PMID 30530006 DOI: 10.1016/j.colsurfb.2018.11.073 |
0.384 |
|
| 2018 |
Gupta N, Jangid AK, Singh M, Kulhari DP, Kulhari H. Designing two-dimensional nanosheets for improving drug delivery to fucose receptor overexpressing cancer cells. Chemmedchem. PMID 30371024 DOI: 10.1002/cmdc.201800575 |
0.422 |
|
| 2018 |
Kadari A, Pooja D, Halley Gora R, Gudem S, Ramana Murthy Kolapalli V, Kulhari H, Sistla R. Design of Multifunctional Peptide Collaborated and Docetaxel Loaded Lipid Nanoparticles for Antiglioma Therapy. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 30244167 DOI: 10.1016/J.Ejpb.2018.09.012 |
0.557 |
|
| 2018 |
Singh MK, Pooja D, Ravuri HG, Gunukula A, Kulhari H, Sistla R. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 40: 48-54. PMID 29496174 DOI: 10.1016/j.phymed.2017.12.021 |
0.327 |
|
| 2017 |
Kulhari H, Telukutla SR, Pooja D, Shukla R, Sistla R, Bansal V, Adams DJ. Peptide grafted and self-assembled poly(γ-glutamic acid)-phenylalanine nanoparticles targeting camptothecin to glioma. Nanomedicine (London, England). PMID 28635550 DOI: 10.2217/Nnm-2017-0067 |
0.494 |
|
| 2017 |
Kadari A, Gudem S, Kulhari H, Bhandi MM, Borkar RM, Kolapalli VR, Sistla R. Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles. Drug Delivery. 24: 224-232. PMID 28156161 DOI: 10.1080/10717544.2016.1245366 |
0.51 |
|
| 2017 |
Nooli M, Chella N, Kulhari H, Shastri NR, Sistla R. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation. Drug Development and Industrial Pharmacy. 43: 611-617. PMID 28005442 DOI: 10.1080/03639045.2016.1275666 |
0.452 |
|
| 2017 |
Swami R, Singh I, Kulhari H, Jeengar MK, Khan W, Sistla R. Correction to: p-Hydroxy benzoic acid-conjugated dendrimer nanotherapeutics as potential carriers for targeted drug delivery to brain: an in vitro and in vivo evaluation Journal of Nanoparticle Research. 19. DOI: 10.1007/s11051-017-4050-0 |
0.341 |
|
| 2016 |
Pooja D, Kulhari H, Kuncha M, Rachamalla SS, Adams DJ, Bansal V, Sistla R. Improving efficacy, oral bioavailability and delivery of paclitaxel using protein-grafted solid lipid nanoparticles. Molecular Pharmaceutics. PMID 27696858 DOI: 10.1021/Acs.Molpharmaceut.6B00691 |
0.613 |
|
| 2016 |
Singh MK, Pooja D, Kulhari H, Jain SK, Sistla R, Chauhan AS. Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 27614111 DOI: 10.1016/J.Ejps.2016.09.005 |
0.462 |
|
| 2016 |
Radhakrishnan R, Kulhari H, Pooja D, Gudem S, Bhargava S, Shukla R, Sistla R. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Chemistry and Physics of Lipids. PMID 27234272 DOI: 10.1016/J.Chemphyslip.2016.05.006 |
0.523 |
|
| 2016 |
Srinivasa Reddy T, Ganga Reddy V, Kulhari H, Shukla R, Kamal A, Bansal V. Synthesis of (Z)-1-(1,3-diphenyl-1H-pyrazol-4-yl)-3-(phenylamino)prop-2-en-1-one derivatives as potential anticancer and apoptosis inducing agents. European Journal of Medicinal Chemistry. 117: 157-166. PMID 27092413 DOI: 10.1016/J.Ejmech.2016.03.051 |
0.343 |
|
| 2016 |
Pooja D, Kulhari H, Adams DJ, Sistla R. Formulation and dosage of therapeutic nanosuspension for active targeting of docetaxel (WO 2014210485A1). Expert Opinion On Therapeutic Patents. PMID 27088623 DOI: 10.1080/13543776.2016.1180365 |
0.624 |
|
| 2016 |
Kulhari H, Pooja D, Shrivastava S, Kuncha M, Naidu VG, Bansal V, Sistla R, Adams DJ. Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer. Scientific Reports. 6: 23179. PMID 27052896 DOI: 10.1038/Srep23179 |
0.507 |
|
| 2016 |
Kulhari H, Pooja D, Kota R, Telukutla SR, Tabor RF, Shukla R, Adams DJ, Sistla R, Bansal V. Cyclic RGDfK Peptide Functionalized Polymeric Nanocarriers for Targeting Gemcitabine to Ovarian Cancer Cells. Molecular Pharmaceutics. PMID 26930230 DOI: 10.1021/Acs.Molpharmaceut.5B00935 |
0.621 |
|
| 2016 |
Pooja D, Tunki L, Kulhari H, Reddy BB, Sistla R. Optimization of solid lipid nanoparticles prepared by a single emulsification-solvent evaporation method. Data in Brief. 6: 15-9. PMID 26759823 DOI: 10.1016/J.Dib.2015.11.038 |
0.344 |
|
| 2015 |
Pooja D, Tunki L, Kulhari H, Reddy BB, Sistla R. Characterization, biorecognitive activity and stability of WGA grafted lipid nanostructures for the controlled delivery of Rifampicin. Chemistry and Physics of Lipids. 193: 11-7. PMID 26409629 DOI: 10.1016/J.Chemphyslip.2015.09.008 |
0.545 |
|
| 2015 |
Kulhari H, Pooja D, Singh MK, Kuncha M, Adams DJ, Sistla R. Bombesin-conjugated nanoparticles improve the cytotoxic efficacy of docetaxel against gastrin-releasing but androgen-independent prostate cancer. Nanomedicine (London, England). 10: 2847-59. PMID 26377157 DOI: 10.2217/Nnm.15.107 |
0.539 |
|
| 2015 |
Srinivasa Reddy T, Kulhari H, Ganga Reddy V, Subba Rao AV, Bansal V, Kamal A, Shukla R. Synthesis and biological evaluation of pyrazolo-triazole hybrids as cytotoxic and apoptosis inducing agents. Organic & Biomolecular Chemistry. 13: 10136-49. PMID 26346902 DOI: 10.1039/C5Ob00842E |
0.333 |
|
| 2015 |
Reddy TS, Kulhari H, Reddy VG, Bansal V, Kamal A, Shukla R. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents. European Journal of Medicinal Chemistry. 101: 790-805. PMID 26231080 DOI: 10.1016/J.Ejmech.2015.07.031 |
0.362 |
|
| 2015 |
Pooja D, Panyaram S, Kulhari H, Reddy B, Rachamalla SS, Sistla R. Natural polysaccharide functionalized gold nanoparticles as biocompatible drug delivery carrier. International Journal of Biological Macromolecules. 80: 48-56. PMID 26093321 DOI: 10.1016/J.Ijbiomac.2015.06.022 |
0.56 |
|
| 2015 |
Kulhari H, Pooja D, Shrivastava S, Telukutala SR, Barui AK, Patra CR, Naidu VG, Adams DJ, Sistla R. Cyclic-RGDfK peptide conjugated succinoyl-TPGS nanomicelles for targeted delivery of docetaxel to integrin receptor over-expressing angiogenic tumours. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 25933692 DOI: 10.1016/J.Nano.2015.04.007 |
0.541 |
|
| 2015 |
Kulhari H, Pooja D, Rompicharla SV, Sistla R, Adams DJ. Biomedical Applications of Trastuzumab: As a Therapeutic Agent and a Targeting Ligand. Medicinal Research Reviews. 35: 849-76. PMID 25847027 DOI: 10.1002/Med.21345 |
0.561 |
|
| 2015 |
Kulhari H, Pooja D, Singh MK, Chauhan AS. Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation. Drug Development and Industrial Pharmacy. 41: 232-8. PMID 24237325 DOI: 10.3109/03639045.2013.858735 |
0.45 |
|
| 2015 |
Pooja D, Kulhari H, Tunki L, Chinde S, Kuncha M, Grover P, Rachamalla SS, Sistla R. Nanomedicines for targeted delivery of etoposide to non-small cell lung cancer using transferrin functionalized nanoparticles Rsc Advances. 5: 49122-49131. DOI: 10.1039/C5Ra03316K |
0.489 |
|
| 2015 |
Swami R, Singh I, Kulhari H, Jeengar MK, Khan W, Sistla R. p-Hydroxy benzoic acid-conjugated dendrimer nanotherapeutics as potential carriers for targeted drug delivery to brain: an in vitro and in vivo evaluation Journal of Nanoparticle Research. 17. DOI: 10.1007/S11051-015-3063-9 |
0.531 |
|
| 2014 |
Pooja D, Kulhari H, Singh MK, Mukherjee S, Rachamalla SS, Sistla R. Dendrimer-TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes. Colloids and Surfaces. B, Biointerfaces. 121: 461-8. PMID 25063311 DOI: 10.1016/J.Colsurfb.2014.06.059 |
0.539 |
|
| 2014 |
Pooja D, Panyaram S, Kulhari H, Rachamalla SS, Sistla R. Xanthan gum stabilized gold nanoparticles: characterization, biocompatibility, stability and cytotoxicity. Carbohydrate Polymers. 110: 1-9. PMID 24906721 DOI: 10.1016/J.Carbpol.2014.03.041 |
0.45 |
|
| 2014 |
Pooja D, Babu Bikkina DJ, Kulhari H, Nikhila N, Chinde S, Raghavendra YM, Sreedhar B, Tiwari AK. Fabrication, characterization and bioevaluation of silibinin loaded chitosan nanoparticles. International Journal of Biological Macromolecules. 69: 267-73. PMID 24863917 DOI: 10.1016/J.Ijbiomac.2014.05.035 |
0.454 |
|
| 2014 |
Kulhari H, Pooja D, Shrivastava S, V G M N, Sistla R. Peptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxel. Colloids and Surfaces. B, Biointerfaces. 117: 166-73. PMID 24632389 DOI: 10.1016/J.Colsurfb.2014.02.026 |
0.536 |
|
| 2014 |
Kulhari H, Kulhari DP, Singh MK, Sistla R. Colloidal stability and physicochemical characterization of bombesin conjugated biodegradable nanoparticles Colloids and Surfaces a: Physicochemical and Engineering Aspects. 443: 459-466. DOI: 10.1016/J.Colsurfa.2013.12.011 |
0.488 |
|
| 2013 |
Kulhari H, Kulhari DP, Prajapati SK, Chauhan AS. Pharmacokinetic and pharmacodynamic studies of poly(amidoamine) dendrimer based simvastatin oral formulations for the treatment of hypercholesterolemia. Molecular Pharmaceutics. 10: 2528-33. PMID 23692066 DOI: 10.1021/Mp300650Y |
0.442 |
|
| 2012 |
Swami G, Pooja D, Kulhari H, Kymonil KM, Saraf SA. Surface modification of poly (l-lactic acid) microspheres for site-specific delivery of ketoprofen for chronic inflammatory disease. Journal of Drug Targeting. PMID 23206275 DOI: 10.3109/1061186X.2012.741137 |
0.459 |
|
| 2011 |
Kulhari H, Pooja D, Narayan H, Meena L, Prajapati SK. Design and evaluation of ocusert for controlled delivery of flurbiprofen sodium. Current Eye Research. 36: 436-41. PMID 21501077 DOI: 10.3109/02713683.2010.542866 |
0.407 |
|
| 2011 |
Kulhari H, Pooja D, Prajapati SK, Chauhan AS. Performance evaluation of PAMAM dendrimer based simvastatin formulations. International Journal of Pharmaceutics. 405: 203-9. PMID 21145960 DOI: 10.1016/J.Ijpharm.2010.12.002 |
0.444 |
|
| Show low-probability matches. |